Skip to main content
Predictmedix AI Inc. logo

Predictmedix AI Inc. — Investor Relations & Filings

Ticker · PMED ISIN · CA74040N1069 LEI · 254900EU3WH68HQM4J21 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 190 across all filing types
Latest filing 2025-09-26 Proxy Solicitation & In…
Country CA Canada
Listing CSE PMED

About Predictmedix AI Inc.

https://predictmedix.com/

Predictmedix AI Inc. is a Life Sciences technology company focused on developing disruptive artificial intelligence tools for health screening and impairment testing. The company's primary offering, the SmartHealth AI Stations, provides quick, noninvasive, and no-contact solutions for assessing individual readiness. Utilizing multispectral cameras and sensors, these AI-powered stations are designed to detect indicators of impairment, extreme fatigue, and infectious diseases. The technology is primarily targeted at improving workplace health and safety and enhancing protection in public environments. Predictmedix also develops specialized AI tools for healthcare applications, including the detection of PTSD implemented in hospital units. A key feature of their technology is the commitment to accurate detection while ensuring user privacy. Furthermore, the company is developing an adaptive-AI engine intended to simulate, optimize, and predict outcomes across multi-site clinical trials.

Recent filings

Filing Released Lang Actions
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “Notice of Meeting and Management Information Circular” for an Annual General and Special Meeting of shareholders, contains proxy solicitation details, voting instructions, record dates, and procedural information for shareholders to vote. These are hallmark features of a proxy statement/solicitation document rather than an annual report, earnings release, or other filing. Therefore, it fits the Proxy Solicitation & Information Statement category.
2025-09-26 English
Other.pdf
Regulatory Filings Classification · 0% confidence The document is a shareholder mailing request form to receive Interim and Annual Financial Statements by mail or email, not the financial statements themselves nor an announcement of their publication. It does not fit specific categories like report content (10-K, IR), dividend notice, M&A, etc. Therefore, it falls under the fallback category for miscellaneous regulatory forms and announcements: Regulatory Filings (RNS).
2025-09-26 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Notice and Access” circular sent to shareholders in advance of the Annual General & Special Meeting, outlining meeting date, matters to be voted on, and instructions for accessing the full management information circular and submitting proxies. This matches the definition for proxy solicitation materials, as it provides information and requests votes from shareholders, rather than being the full annual report or simply announcing a report publication.
2025-09-26 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING,” detailing meeting agenda items, proxy voting instructions, record date, and how to obtain meeting materials. It is clearly a proxy solicitation notice sent to shareholders to request votes and provide information ahead of the AGM. This corresponds to the Proxy Solicitation & Information Statement category (PSI).
2025-09-26 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a Business Wire press release announcing a product expansion into mobile diagnostics with a new AI-driven diabetes screening platform. It does not contain financial results, voting information, management changes, or regulatory/legal content. It is not a report itself but a general corporate announcement. None of the specific filing categories (e.g., 10-K, IR, ER, CAP, M&A, etc.) apply, so it falls into the fallback category of general regulatory filings (RNS).
2025-07-15 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a Business Wire press release about Predictmedix AI’s technology and regulatory environment shift by the FDA. It is not a financial report (no earnings, no interim/annual report), not a shareholder meeting notice, management change, dividend, M&A, share issue or insider dealing, nor is it a presentation or Excel supplement. It does not attach or announce a specific regulatory filing or report. Therefore it falls into the catch-all category for general corporate/regulatory announcements: Regulatory Filings (Code: RNS).
2025-07-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.